Shares of MaxLinear shifted sharply higher in pre-market trading, up 10.1% to $71.86, after the chipmaker reported a Q3 earnings beat and issued Q4 guidance well above Wall Street estimates. The rebound follows a punishing 13.87% sell-off in the regular session on October 22 — a whiplash sequence that captures the tension between MaxLinear's accelerating AI-driven growth and investor anxiety over whether the stock's valuation already prices in the best-case scenario.
• A Revenue Surge Powered by AI Data Centers
Q3 revenue hit $218.1 million, up 29% sequentially and 72% year over year. The engine: infrastructure revenue grew 210% year over year to roughly $125 million, now larger than all other business lines combined. That means more than half of MaxLinear's sales now come from optical chips that move data inside AI-focused data centers — a single-product concentration that amplifies both opportunity and risk.
• Q4 Guidance Blew Past the Street
MaxLinear projected Q4 revenue of $240–$260 million versus the analyst consensus of $226.7 million.
The midpoint of $250 million exceeds consensus by $23.3 million.
Management also raised its full-year 2026 optical data center revenue outlook to $250–$270 million , signaling order books are firming, not softening.
• Profitability Is Turning Real — But Cash Flow Isn't There Yet
Non-GAAP gross margin reached 60% and non-GAAP diluted EPS was $0.62 , beating the $0.56 estimate by $0.06.
Adjusted operating margin expanded to 29.5% from 12.1% a year ago. Yet cash flow used in operating activities was approximately $13.6 million — the company is spending cash, not generating it, partly because increased wafer prepayments are impacting operating cash flow. Until cash earnings catch up to accounting earnings, bulls are investing on a promise.
• The Valuation Debate Isn't Going Away
MaxLinear's price-to-sales ratio of 10.3x far exceeds its historical median of 3.8x.
Insiders have sold $60.6 million in shares over the past 12 months.
Implied full-year 2026 revenue of roughly $774 million versus the $747 million estimate justifies some premium, but the stock's 52-week range of $12.77 to $128.30 tells you this is a name where sentiment swings violently. Investors should watch whether Q4 cash flow finally turns positive — that's the number that will separate hype from durability.